News and Reports
-
Numab Therapeutics and Ono Pharmaceutical Announce an Option and Collaboration Agreement to Develop Multi-specific Antibody NM49 for Treatment of Cancer
14 February 2024Download -
Encoded Therapeutics Announces US IND Clearance and Australian CTA Approval for Dravet Syndrome Gene Therapy Candidate ETX10
6 February 2024Download -
Cathay Biotech Inc. and 3P.COM Co. Limited Signed Joint Venture Agreement to Propel Thermoplastic Bio-Based Polyamide Composites Innovation
2 February 2024Download -
Cathay Biotech’s Progress Report in Bio-based High Temperature Polyamides (PPA) and Composite Technologies
2 February 2024Download -
ArriVent Announces Pricing of Upsized Initial Public Offering
25 January 2024Download -
eGenesis and OrganOx Announce Successful Use of a Genetically Engineered Porcine Liver with a Human Donor
19 January 2024Download -
Upstream Bio Announces Dosing of First Patients in a Phase 2 Clinical Trial of Verekitug (UPB-101) in Chronic Rhinosinusitis with Nasal Polyps (CRSwNP)
3 January 2024Download -
Shape Memory Medical Announces Sublicense of Intellectual Property
11 December 2023Download -
Synthetic Biology’s Great Attack - Dr. Xiucai Liu, Chairman of Cathay Biotech, discussing the status and future of the synthetic biology industry
30 November 2023Download -
Dren Bio Strengthens Leadership Team with Appointment of Amit Mehta, Ph.D., as Chief Operating Officer and Chief Business Officer
30 October 2023Download -
Upstream Bio Announces Positive Phase 1b Interim Data in Asthma and Company Progress Toward Phase 2
24 October 2023Download -
Numab Therapeutics Announces First Patient Dosed in Phase 1 Multiple Ascending Dose (MAD) Study of NM26 for Moderate to Severe Atopic Dermatitis
19 October 2023Download -
Monte Rosa Therapeutics Announces Strategic Collaboration with Roche to Discover Novel Molecular Glue Degraders Targeting Cancer and Neurological Diseases
17 October 2023Download -
Monte Rosa Therapeutics Announces Interim PK/PD and Clinical Data for MRT-2359 in Phase 1/2 Trial for MYC-Driven Solid Tumors
17 October 2023Download -
eGenesis Announces Publication in Nature of Landmark Preclinical Data Demonstrating Long-Term Survival with Genetically Engineered Porcine Kidneys
11 October 2023Download -
Karius Test® Improves the Diagnosis and Management of Pneumonia in Patients Undergoing Treatment for Blood Cancer
10 October 2023Download -
Valo Health and Novo Nordisk to collaborate to discover and develop novel treatments for cardiometabolic diseases using human data and artificial intelligence
25 September 2023Download -
Swixx Biopharma Expands to Mena Region, Appoints Manar Al Nahar as Regional General Manager, Mena
18 September 2023Download -
Boditech Med and SphingoTec close Market Development Agreement to Boost Commercialization of Kidney Function Biomarker PenKid
31 August 2023Download -
FORE Biotherapeutics Announces $75M in Series D Financing and CEO Transition
23 August 2023Download -
ADARx Pharmaceuticals, A Leader in Next Generation RNA Therapeutics, Announces Oversubscribed $200 Million Series C Financing
9 August 2023Download -
Upstream Bio Announces $200M Series B Financing to Advance UPB-101 for Allergic and Inflammatory Diseases
8 June 2023Download -
Upstream Bio Presents New Phase 1 Clinical Data on UPB-101 at the American Thoracic Society (ATS) International Conference
22 May 2023Download -
Numab Therapeutics Announces First Subject Dosed in Phase 1 Clinical Study of NM26 Program
15 May 2023Download -
Swixx and Beigene Partner in 13 Countries of Central and Eastern Europe, Greece, Cyprus and Malta
9 May 2023Download